Estep et al. demonstrated that IL-20 expression was increased in the liver tissues of NAFLD patients, negatively correlated with microRNAs (miRNAs) in the white adipose tissue of patients, and positively correlated with inflammatory markers and the severity of NAFLD. Here, IL20 is linked to metabolic dysfunction-associated steatotic liver disease.